KRT7-AS

Across TCGA pan-cancer cohorts, KRT7-AS RNA is linked to patient survival in 25 of 34 cancer types, making it the most broadly survival-associated KRT7-AS data layer.

The strongest signal is observed in bladder urothelial carcinoma (BLCA), where higher KRT7-AS RNA is associated with better overall survival. In most high-consensus cancer types, elevated KRT7-AS expression acts as an unfavorable survival marker, although some lineages such as BLCA and KIRP show a favorable association.

BLCA, UCEC, and UVM are the cancer types where KRT7-AS RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
BLCA	OS	Median	All	0.510	0.341	<.001	87	view →
UCEC	DFS	Tertile	All	0.459	0.713	.002	62	view →
UVM	OS	Tertile	All	0.293	0.823	<.001	60	view →
OV	OS	Quartile	All	0.304	0.440	.003	60	view →
LGG	DFS	Median	All	0.289	0.461	<.001	51	view →
THCA	OS	Tertile	II,III,IV	0.899	1.000	.004	42	view →
KIRP	DFS	Tertile	All	0.948	0.817	.001	34	view →
ESCA	OS	Median	All	0.440	1.000	.008	32	view →
PAAD	DFS	Tertile	All	0.233	0.433	.022	16	view →
ACC	DFS	Median	IV	0.453	0.108	.019	15	view →
MESO	OS	Quartile	All	0.468	0.713	.009	13	view →
UCS	DFS	Tertile	IV	0.956	0.381	.024	12	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 25 lineages.

KRT7-AS–BLCA (OS)

Open the BLCA breakdown →